Search results
GSK to Sell Remaining $1.6 Billion Stake in Haleon
Bloomberg via Yahoo Finance· 4 days ago(Bloomberg) -- GSK Plc will sell its remaining stake in Haleon Plc for £1.25 billion ($1.6 billion), completing the drugmaker’s separation from the...
GSK raises $1.5 billion from offloading Haleon stake at a discount
Reuters via AOL· 4 days agoGSK sold around 385 million shares at 324 pence apiece, amounting to a 4.2% stake in Haleon. The...
GSK intends to sell its remaining stake in Haleon
Reuters via AOL· 4 days agoThe latest offload will mark the fourth set of disposal GSK has had in the Sensodyne toothpaste maker in a year. GSK, which initially retained a near 13%...
GSK PLC's Dividend Analysis
GuruFocus.com via Yahoo Finance· 6 days agoGSK PLC (NYSE:GSK) recently announced a dividend of $0.38 per share, payable on July 11, 2024, with the ex-dividend date set for May 16, 2024. As...
GSK raises $1.5 billion from sale of remaining Haleon stake
Reuters via Yahoo Finance· 4 days agoThe sale will allow GSK to sharpen its focus on vaccines, cancer and infectious diseases, which are...
Department of Health - Abu Dhabi partners with GSK to Establish Regional Vaccine Distribution Hub
WRBL Columbus· 6 days agoDhabi (DoH), the regulator of the healthcare sector in the Emirate, has signed a Memorandum of Understanding (MoU) with GSK, a leading biopharma company, during Abu Dhabi ...
US FDA declines to approve expanded use of Dynavax's hepatitis B vaccine
Reuters· 6 days ago, opens new tab said on Tuesday the U.S. Food and Drug Administration (FDA) has declined to approve...
Moderna Stock Rebounds From Its RSV Vaccine Fallout — Is It A Buy, Again?
Investor's Business Daily· 6 days agoIf approved, Moderna plans to launch the vaccine this fall for people age 60 and older. This puts it...
Elegen Raises $35M in Series B Financing Round
GenomeWeb News· 6 days agoSynthetic DNA maker Elegen said Tuesday that it has raised $35 million in a Series B financing. Triatomic Capital led the round, joined by GSK and John Ballantyne, cofounder ...
GSK (LON:GSK) Hits New 52-Week High at $1,821.00
ETF DAILY NEWS· 5 days agoShares of GSK plc (LON:GSK – Get Free Report) hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as GBX 1,821 ($22.87 ...
